374 Identification of Psychosis Risk Biomarkers in 22q11DS for future translational studies

OBJECTIVES/GOALS: 22q.11 deletion syndrome (22q11DS) is a genomic syndrome that elevates risk for psychosis >20-fold. We used a battery of cognitive and psychophysiological psychosis-risk biomarkers in 22q11DS patients and healthy subjects in order to identify biomarkers of psychosis in 22q11DS t...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, David, Imes, Sid, Ruben, Gabrielle, Cuthbert, Bruce, Hershey, Brett, Walker, Elaine, Ousley, Opal, Cubells, Joseph, Duncan, Erica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Precision Medicine/Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129592/
http://dx.doi.org/10.1017/cts.2023.412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129592/
http://dx.doi.org/10.1017/cts.2023.412

Ejemplares similares